Akari Therapeutics

AKTX

AKTX Akari Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    AKTX Chart
    See on advanced chart >

    About

    Akari Therapeutics, Plc is a biopharmaceutical company dedicated to the discovery and development of novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs. Celsus believe that it has created a new class of synthetic drugs that it term...
    • Highlight
      A biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      01/31/2014
    • Established Date
      10/07/2004
    • Full-time Employees
      12
    • Address
      75/76 Wimpole Street London W1G 9RT United Kingdom
    • Tel
      44-20-80040270
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)
    cache time: 2024-04-23 10:20:39